NCT01398423 - INV-144 Versus Losartan in Hypertension and Type 2 Diabetes Mellitus Patients With Macroalbuminuria | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions

HypertensionDiabetes Mellitus, Type 2

Interventions

DRUG

Active Control

Losartan potassium (50 mg) plus placebo to match alpha lipoic acid (600 mg)

DRUG

INV-144

INV-144 is a combination drug product consisting of losartan potassium (50mg) and alpha lipoic acid (600 mg)

Trial Locations (19)

21136

Reisterstown

23507

Norfolk

27511

Cary

27610

Raleigh

27834

Greenville

28562

New Bern

29801

Aiken

30084

Tucker

31217

Macon

33015

Miami

34741

Kissimmee

55430

Brooklyn Center

78215

San Antonio

78228

San Antonio

91324

Northridge

91942

La Mesa

92505

Riverside

92780

Tustin

92844

Garden Grove